Laetitia Pouzol
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 31, 2024
ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating Effects.Laetitia Pouzol, Anna Sassi, Mélanie Tunis
|Jul 17, 2023
Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes.Urs Christen, Laetitia Pouzol, Mélanie Tunis
|Mar 08, 2023
Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies.Emmanuel A Meyer, Päivi Äänismaa, Eric A Ertel
|Feb 17, 2021
ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.Laetitia Pouzol, Nadège Baumlin, Anna Sassi
Pageof 1
